Sterling Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
12,993
+10,811
+495% +$1.66M 0.04% 322
2025
Q4
$380K Buy
2,182
+1,195
+121% +$218K 0.01% 1071
2025
Q3
$142K Sell
987
-12
-1% -$1.47K ﹤0.01% 1419
2025
Q2
$101K Buy
999
+818
+452% +$62.5K ﹤0.01% 1357
2025
Q1
$13.8K Buy
181
+4
+2% +$306 ﹤0.01% 1769
2024
Q4
$12.2K Buy
177
+18
+11% +$1.3K ﹤0.01% 2073
2024
Q3
$11.6K Buy
+159
New +$11.7K ﹤0.01% 1537

Other funds holding INSM

Sterling Capital Management's INSM Position: Q1 2026 in Review

Sterling Capital Management increased its Insmed (INSM) stake by 495% in Q1 2026, buying an estimated $1.66M and bringing the position to 12,993 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #322.

Sterling Capital Management first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Sterling Capital Management held 12,993 shares of Insmed worth $2.12M as of Q1 2026.
  • Sterling Capital Management bought 10,811 Insmed shares in Q1 2026, an estimated $1.66M.
  • Insmed made up 0.04% of Sterling Capital Management's portfolio in Q1 2026, its #322 holding.
  • Sterling Capital Management first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.